MCF Advisors’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-182
Closed -$3K 491
2020
Q3
$3K Hold
182
﹤0.01% 432
2020
Q2
$3K Hold
182
﹤0.01% 429
2020
Q1
$2K Sell
182
-1
-0.5% -$14 ﹤0.01% 431
2019
Q4
$4K Hold
183
﹤0.01% 407
2019
Q3
$3K Hold
183
﹤0.01% 411
2019
Q2
$2K Hold
183
﹤0.01% 420
2019
Q1
$3K Hold
183
﹤0.01% 419
2018
Q4
$3K Hold
183
﹤0.01% 428
2018
Q3
$4K Hold
183
﹤0.01% 415
2018
Q2
$8K Hold
183
﹤0.01% 354
2018
Q1
$12K Hold
183
﹤0.01% 325
2017
Q4
$13K Hold
183
﹤0.01% 319
2017
Q3
$17K Hold
183
﹤0.01% 311
2017
Q2
$12K Hold
183
﹤0.01% 354
2017
Q1
$40K Hold
183
0.01% 251
2016
Q4
$17K Hold
183
﹤0.01% 279
2016
Q3
$25K Hold
183
0.01% 260
2016
Q2
$19K Hold
183
﹤0.01% 300
2016
Q1
$30K Hold
183
0.01% 236
2015
Q4
$60K Hold
183
0.02% 164
2015
Q3
$59K Sell
183
-92
-33% -$40.4K 0.02% 167
2015
Q2
$109K Hold
275
0.03% 135
2015
Q1
$135K Hold
275
0.03% 122
2014
Q4
$98K Hold
275
0.03% 139
2014
Q3
$70K Hold
275
0.02% 159
2014
Q2
$70K Hold
275
0.02% 156
2014
Q1
$70K Hold
275
0.02% 153
2013
Q4
$70K Hold
275
0.02% 148
2013
Q3
$70K Hold
275
0.04% 148
2013
Q2
$70K Buy
+275
New +$38.9K 0.04% 135

Other funds holding LUMO

MCF Advisors's LUMO Position: Q4 2020 in Review

MCF Advisors sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2020, closing a stake of 182 shares — an estimated $3K sold.

MCF Advisors first reported a position in LUMO in Q2 2013 and held it in 30 quarters. The position peaked at $135K in Q1 2015. 47 funds tracked by Wall St. Rank hold LUMO as of Q4 2020.

  • MCF Advisors reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • MCF Advisors sold 182 Lumos Pharma, Inc. Common Stock shares in Q4 2020, an estimated $3K.
  • MCF Advisors first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 30 quarters.
  • MCF Advisors's Lumos Pharma, Inc. Common Stock position peaked at $135K in Q1 2015.
  • 47 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2020.

Based on MCF Advisors's 13F filing for Q4 2020, filed 9 Feb 2021.